Alembic制药公司得到林业发展局批准用于治疗高血压和心血管炎的通用Diltiazem胶囊。 Alembic Pharmaceuticals gets FDA approval for generic Diltiazem capsules to treat hypertension and angina.

Alembic制药公司获得美国林业发展局批准其用于治疗高血压和动脉炎的通用Diltiazem盐酸长期释放胶囊。 Alembic Pharmaceuticals received US FDA approval for its generic Diltiazem Hydrochloride extended-release capsules, used to treat hypertension and angina. 这些胶囊可用120毫克、180毫克、240毫克、300毫克和360毫克体积,可单独使用,也可使用其他药物。 Available in 120 mg, 180 mg, 240 mg, 300 mg, and 360 mg strengths, these capsules can be used alone or with other medications. FDA 的批准是 Alembic 已获得的 218 项 ANDA 批准之一，过去一年的市场规模估计为 1.053 亿美元。 The FDA approval marks one of 218 ANDA approvals Alembic has received, with a market size of $105.3 million estimated for the past year.